Skip to main content

Table 1 Clinical and laboratory features along with rK39 results of patients with visceral Leishmaniasis and Controls

From: The rK39 strip test is non-predictor of clinical status for kala-azar

Study entry

 

VL patients

Controls

 

Pre-treated

Post-treated (180 day)

 

No.

100

50

110

Age (years)

26 ± 4.5

-

27 ± 4.1

Duration of illness (months)

4.4 ± 0.45

-

-

Weight (kg)

40.1 ± 6.6

45.4 ± 5.2

60 ± 5.4

Karnofsky score

71.8 ± 2.5

85.4 ± 2.7

100

Spleen size(cm)

8.4 ± 2.4

4.0 ± 0.6

-

Splenic aspirate score

2.9 ± 0.4

-

-

WBC count(× 103/mm3)

3.49 ± 0.59

6.4 ± 0.6

9.1 ± 2.3

Hemoglobin (g/dL)

6.9 ± 0.48

11.2 ± 0.76

14.2 ± 2.1

Platelet count(× 103/mm3)

72 ± 0.35

270 ± 0.5

254 ± 23

rK39 positivity

98*

50*

5*

  1. *indicates total no. of positive.